Sharescart Research Club logo
Apollo Green 56 (-3.4%)ASK Investment 925 (0%)CIAL 444 (1.4%)CSK 258 (-3%)ESDS Software 468 (4.5%)Garuda Aerospace 468 (-3.5%)India Carbon 895 (0%)Indian Potash 2850 (0%)Inox Clean 725 (0%)Lava 52 (0%)Matrix Gas 14 (-12.5%)Motilal Oswal 12.5 (-3.5%)MSEI 6.35 (1.6%)NCDEX 368 (-5.2%)NSE 1995 (1%)OYO 24 (0%)OYO Assets 9.95 (-17.1%)Pharmeasy 6.25 (0%)Philips India 1250 (0%)Polymatech Electronics 56 (-9.7%)RRP S4E 158 (-6%)SBI Mutual 768 (-0.9%)Taparia Tools 6050 (0%)Ticker Ltd 32 (0%)Zepto 42 (-14.3%)

15 Days Price Change

Crop Life Science IPO

Closing In

  • days
  • Hours
  • Minutes
  • Seconds
Profile
Issue Size --
Profile
Price Range 52  to  52 per share
Profile
Min Investment ₹52
Profile
Lot Size 1
Profile
Face Value ₹10
Profile
Draft Prospectus
Invest Before the IPO Goes Live

Buy unlisted shares early and participate in the growth before public listing.

Profile
  • Basic Info
  • IPO Tentative Timetable
  • IPO Lot Size
  • Subscription Status
  • Financials
  • Profit & Loss
  • Balance Sheet
  • Cash Flow
  • Ratios
  • Growth Rates
  • Other info

Overview

Crop Life Science Ltd is a pioneering agricultural biotechnology company dedicated to enhancing global food production and sustainability. With a commitment to innovative solutions, Crop Life Science Ltd focuses on developing advanced crop protection products, precision agricultural technologies, and bioengineering solutions to address pressing challenges in modern agriculture. By harnessing cutting-edge scientific research, the company aims to optimize crop yields, minimize environmental impact, and promote efficient resource utilization. Crop Life Science Ltd's comprehensive approach encompasses both traditional agricultural practices and state-of-the-art advancements, reflecting its dedication to shaping a more productive and ecologically balanced future for agriculture. Read More

Basic Info

Face Value 10 per share

Price 52  to  52 per share

P/E (x) 15.8

Sales( Cr.) 201

PAT( Cr.) 6

EPS 3.3

Draft Prospectus

Exchange NSE-SME

Promoter

Company Promoters

Mr. Rajesh Lunagariya Mr. Ashvinkumar Lunagaria

Pre Issue Share Holding 29.97%

Post Issue Share Holding 20.98%

Listing Details:

Listing Price: 55.95

Listing Gain: 7.06%

Current Price: 42.5

Gain On Issue: 42.5 | 0%

GMP: --

GMP %: -- %

IPO Tentative Timetable

Opening Date Aug 18, 2023
Closing Date Aug 22, 2023
Allotment Aug 23, 2023
Refund Aug 24, 2023
Delivery of Shares Aug 24, 2023
Listing Date Aug 25, 2023

IPO Lot Size

Application Lots Shares Amount
Retail (Min) 1 2000 104,000
Retail (Max) 1 2000 104,000
S-HNI (Min) 2 4000 208,000
S-HNI (Max) 9 18000 936,000
B-HNI (Min) 10 20000 1,040,000

Objective of the Issue

1. Working capital requirement 2. General Corporate Purpose 3. Meeting Public Issue Expenses.

Issue

Category Nos Bid Bid (x)
QIB 0 0 0x
NII 2570000 4009200 1.6x
Retail 2570000 18375500 7.2x
EMP 0 0 0x
Total 5140000 22410400 4.4x

Net Sales (in cr.)

Total Income (in cr.)

Operating Profit (in cr.)

Net Profit (in cr.)

Shareholder Funds (in cr.)

Total Assets (in cr.)

Crop Life Science Profit & Loss

#(Fig in Cr.) Mar 2023 Mar 2024 Mar 2025 TTM
Net Sales 131 199 201
Other Income 1 2 2
Total Income 132 201 202
Total Expenditure 119 186 185
Operating Profit 13 15 17
Interest 3 3 5
Depreciation 4 3 5
Exceptional Income / Expenses 0 0 0
Profit Before Tax 6 8 8
Provision for Tax 2 2 2
Profit After Tax 4 6 6
Adjustments 0 0 0
Profit After Adjustments 4 6 6
Adjusted Earnings Per Share 3.4 3.5 3.4

Crop Life Science Balance Sheet

#(Fig in Cr.) Mar 2023 Mar 2024 Mar 2025
Shareholder's Funds 41 72 77
Minority's Interest 0 4 4
Borrowings 6 6 3
Other Non-Current Liabilities 1 5 5
Total Current Liabilities 56 95 95
Total Liabilities 103 182 184
Fixed Assets 16 39 38
Other Non-Current Assets 0 1 2
Total Current Assets 87 142 144
Total Assets 103 182 184

Crop Life Science Cash Flow

#(Fig in Cr.) Mar 2023 Mar 2024 Mar 2025
Opening Cash & Cash Equivalents 2 1 2
Cash Flow from Operating Activities 2 -8 -2
Cash Flow from Investing Activities -4 -3 -4
Cash Flow from Financing Activities 1 13 4
Net Cash Inflow / Outflow -2 2 -1
Closing Cash & Cash Equivalent 0 2 1

Crop Life Science Ratios

# Mar 2023 Mar 2024 Mar 2025
Earnings Per Share (Rs) 3.39 3.51 3.44
CEPS(Rs) 6.48 5.39 6.08
DPS(Rs) 0 0 0
Book NAV/Share(Rs) 33.8 41.85 45.19
Core EBITDA Margin(%) 8.97 6.35 7.75
EBIT Margin(%) 6.76 5.79 6.26
Pre Tax Margin(%) 4.27 4.08 3.89
PAT Margin (%) 3.1 3.03 2.79
Cash Profit Margin (%) 5.93 4.65 5.2
ROA(%) 3.95 4.22 3.06
ROE(%) 10.04 10.72 7.51
ROCE(%) 13.33 13.56 11.35
Receivable days 90.55 100.91 133.34
Inventory Days 72.84 60.65 80.71
Payable days 79.13 90.76 121.49
PER(x) 0 10.47 14.84
Price/Book(x) 0 0.88 1.13
Dividend Yield(%) 0 0 0
EV/Net Sales(x) 0.29 0.46 0.63
EV/Core EBITDA(x) 2.99 6.24 7.31
Net Sales Growth(%) 0 51.35 1
EBIT Growth(%) 0 29.63 9.12
PAT Growth(%) 0 47.77 -6.9
EPS Growth(%) 0 3.58 -2.19
Debt/Equity(x) 0.64 0.44 0.52
Current Ratio(x) 1.55 1.5 1.52
Quick Ratio(x) 1.08 1.08 1
Interest Cover(x) 2.71 3.39 2.64
Total Debt/Mcap(x) 0 0.5 0.46

Sihora Industries Growth Rates

# 1 Year 3 Year 5 Year 10 Year
Sales CAGR 1% 0% 0% 0%
Operating Profit CAGR 13% 0% 0% 0%
PAT CAGR 0% 0% 0% 0%
# 1 Year 3 Year 5 Year 10 Year
Share Price CAGR -15% NA% NA% NA%
ROE Average 8% 9% 9% 9%
ROCE Average 11% 13% 13% 13%

Company Contact Information

Crop Life Science Ltd.

6th Floor A B S Tower, Near Chakli Circle Old Padra Road

IPO Lead Manager(s)

Crop Life Science Ltd.

Interactive Financial Services Ltd.

Registrar Info

Crop Life Science Ltd.

Frequently Asked Questions

All You Need To Know About IPO

When you leave without vesting, generally unvested ESOPs are cancelled. Vested ESOPs usually can be exercised after you depart, often within 3 to 6 months, depending on the company's ESOP plan.

For companies listed on a stock exchange, you can sell the shares any time after you exercise the ESOP option and the shares are in your demat account. If the company is unlisted or otherwise a startup, you can only sell the shares if and when the company announces a buyback or has a process for secondary sales.

Whenever you exercised your options to hold shares, you entered into a market risk situation, and if the valuation of the company drops, so do the shares.

Yes. ESOPs are valuable to the employer in that the employer is able to retain the best talent, align employee interests with company goals, and preserve cash while rewarding performance.

Wealth Icon
Don’t Miss Out on Unlisted Shares

Open your account today and gain instant access to top unlisted shares and pre-IPO opportunities.

whatsapp